WallStreetZenWallStreetZen

NASDAQ: KPRX
Kiora Pharmaceuticals Inc Stock Ownership - Who owns Kiora Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Kiora Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Carmine N. StengoneDirector2024-09-111,250$3.68
$4.60kBuy
Aron ShapiroDirector2024-09-103,000$3.60
$10.80kBuy

1 of 1

KPRX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when KPRX insiders and whales buy or sell their stock.

KPRX Shareholders

What type of owners hold Kiora Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Armistice Capital LLC245.68%7,478,202$19.82MInsider
Innoven Partenaires Sa Ipsa47.98%1,460,479$3.87MInsider
Ventech Capital II47.04%1,431,814$3.79MInsider
Private Equity Natixis22.15%674,205$1.79MInsider
Barbara Wirostko15.24%463,808$1.23MInsider
Aigh Capital Management LLC7.11%216,345$573.31kInstitution
Nantahala Capital Management LLC6.94%211,110$559.44kInstitution
Michael Garanzini6.45%196,250$520.06kInsider
Stonepine Capital Management LLC5.85%178,000$471.70kInstitution
Adar1 Capital Management LLC5.49%167,111$442.84kInstitution

1 of 3

KPRX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
KPRX7.08%92.92%Net Buying
RNAZ0.87%99.13%
ADIL1.08%21.16%
CELZ2.66%1.36%Net Selling
VYNE23.70%76.30%Net SellingNet Selling
View Top Biotech Stocks

Kiora Pharmaceuticals Stock Ownership FAQ

Who owns Kiora Pharmaceuticals?

Kiora Pharmaceuticals (NASDAQ: KPRX) is owned by 30.61% institutional shareholders, 401.60% Kiora Pharmaceuticals insiders, and 0.00% retail investors. Armistice Capital LLC is the largest individual Kiora Pharmaceuticals shareholder, owning 7.48M shares representing 245.68% of the company. Armistice Capital LLC's Kiora Pharmaceuticals shares are currently valued at $21.25M.

If you're new to stock investing, here's how to buy Kiora Pharmaceuticals stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.